HISTOGENICS CORP's ticker is HSGX and the CUSIP is 43358V109. A total of 29 filers reported holding HISTOGENICS CORP in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $19,000 | +1800.0% | 98,161 | +788.9% | 0.00% | – |
Q1 2019 | $1,000 | -92.3% | 11,043 | -92.6% | 0.00% | – |
Q4 2018 | $13,000 | -89.5% | 149,387 | +675.9% | 0.00% | – |
Q2 2015 | $124,000 | -59.9% | 19,254 | -37.7% | 0.00% | -100.0% |
Q1 2015 | $309,000 | -6.4% | 30,930 | +3.1% | 0.00% | 0.0% |
Q4 2014 | $330,000 | – | 30,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 2,690,570 | $6,161,000 | 0.24% |
Palo Alto Investors LP | 454,545 | $1,041,000 | 0.08% |
CARL DOMINO INC | 20,910 | $48,000 | 0.04% |
SABBY MANAGEMENT, LLC | 150,630 | $345,000 | 0.02% |
Mount Lucas Management LP | 7,500 | $17,000 | 0.00% |
J.P. Morgan Private Wealth Advisors LLC | 48,455 | $111,000 | 0.00% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 23,780 | $54,000 | 0.00% |
FMR LLC | 1,906,720 | $4,366,000 | 0.00% |
BlackRock Investment Management, LLC | 979 | $2,000 | 0.00% |
BlackRock Fund Advisors | 15,938 | $36,000 | 0.00% |